HL7 and IHTSDO

On April 5, 2009 Health Level Seven® Inc. (HL7®), the leading authority for global healthcare IT standards, and the International Health Terminology Standards Development Organisation (IHTSDO®), the leading provider of standardized clinical terminology, today announced a collaboration agreement that will foster interoperability and lead to improvements in patient safety by eliminating gaps and overlaps between the HL7 and IHTSDO standards.

The terms of this agreement complement both organizations’ involvement in the Joint Initiative on SDO Global Health Informatics Standardization, which was established to enable common, timely health informatics standards by addressing counterproductive standardization efforts. The Joint Initiative seeks to promote interoperability by coordinating standards strategies and plans and using mutually agreed upon processes that meet international standardization needs. For more information, please read the press release.

About HL7

Founded in 1987, Health Level Seven, Inc. (www.HL7.org) is a not-for-profit, ANSI-accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7’s more than 2,000 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare.

HL7’s endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technologies; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; QuadraMed Corporation; Quest Diagnostics Inc.; Siemens Medical 3 Solutions Health Services; St. Jude Medical; Sunquest Information Systems; Thomson Reuters; the US Department of Defense, Military Health System; and the US Department of Veterans Affairs. Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and Uruguay. For more information, please visit the HL7 website.



About IHTSDOSNOMED CTJoin UsNewsProjectsPublicationsMembersContact Us
Search Print FAQ
Vision Strategic Directions Governance and Advisory Harmonization American Academy of Ophthalmology HL7 ICN IEEE LOINC & NPU openEHR WHO WONCA Collaborative Space IHTSDO Conferences People and Office Articles of Association FAQ	HL7 and IHTSDO On April 5, 2009 Health Level Seven® Inc. (HL7®), the leading authority for global healthcare IT standards, and the International Health Terminology Standards Development Organisation (IHTSDO®), the leading provider of standardized clinical terminology, today announced a collaboration agreement that will foster interoperability and lead to improvements in patient safety by eliminating gaps and overlaps between the HL7 and IHTSDO standards. The terms of this agreement complement both organizations’ involvement in the Joint Initiative on SDO Global Health Informatics Standardization, which was established to enable common, timely health informatics standards by addressing counterproductive standardization efforts. The Joint Initiative seeks to promote interoperability by coordinating standards strategies and plans and using mutually agreed upon processes that meet international standardization needs. For more information, please read the press release. About HL7 Founded in 1987, Health Level Seven, Inc. (www.HL7.org) is a not-for-profit, ANSI-accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7’s more than 2,000 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7’s endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technologies; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; QuadraMed Corporation; Quest Diagnostics Inc.; Siemens Medical 3 Solutions Health Services; St. Jude Medical; Sunquest Information Systems; Thomson Reuters; the US Department of Defense, Military Health System; and the US Department of Veterans Affairs. Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and Uruguay. For more information, please visit the HL7 website.